Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy

Hatem A. Azim, Andrea Vingiani, Fedro Peccatori, Giuseppe Viale, Sherene Loi, Giancarlo Pruneri

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Tumour infiltrating lymphocytes (TILs) is one of the most exciting breast cancer biomarkers, yet no data is available on its prevalence in tumours diagnosed during pregnancy. Methods: We evaluated the prevalence of TILs (stromal and intratumoural) in pregnant and non-pregnant young breast cancer patients. Results: 11/116 (9.6%) of the non-pregnant and 2/86 (2.3%) pregnant patients had TILs≥50% (p

Original languageEnglish
Pages (from-to)290-293
Number of pages4
JournalBreast
Volume24
Issue number3
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Tumor-Infiltrating Lymphocytes
Breast Neoplasms
Pregnancy
Tumor Biomarkers
Neoplasms

Keywords

  • Biology
  • Breast cancer during pregnancy
  • Tumour infiltrating lymphocytes
  • Young

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy. / Azim, Hatem A.; Vingiani, Andrea; Peccatori, Fedro; Viale, Giuseppe; Loi, Sherene; Pruneri, Giancarlo.

In: Breast, Vol. 24, No. 3, 01.06.2015, p. 290-293.

Research output: Contribution to journalArticle

Azim, Hatem A. ; Vingiani, Andrea ; Peccatori, Fedro ; Viale, Giuseppe ; Loi, Sherene ; Pruneri, Giancarlo. / Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy. In: Breast. 2015 ; Vol. 24, No. 3. pp. 290-293.
@article{58a0b93eb03e4f0f9ef3f1baf36f1139,
title = "Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy",
abstract = "Background: Tumour infiltrating lymphocytes (TILs) is one of the most exciting breast cancer biomarkers, yet no data is available on its prevalence in tumours diagnosed during pregnancy. Methods: We evaluated the prevalence of TILs (stromal and intratumoural) in pregnant and non-pregnant young breast cancer patients. Results: 11/116 (9.6{\%}) of the non-pregnant and 2/86 (2.3{\%}) pregnant patients had TILs≥50{\%} (p",
keywords = "Biology, Breast cancer during pregnancy, Tumour infiltrating lymphocytes, Young",
author = "Azim, {Hatem A.} and Andrea Vingiani and Fedro Peccatori and Giuseppe Viale and Sherene Loi and Giancarlo Pruneri",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.breast.2015.01.009",
language = "English",
volume = "24",
pages = "290--293",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy

AU - Azim, Hatem A.

AU - Vingiani, Andrea

AU - Peccatori, Fedro

AU - Viale, Giuseppe

AU - Loi, Sherene

AU - Pruneri, Giancarlo

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Background: Tumour infiltrating lymphocytes (TILs) is one of the most exciting breast cancer biomarkers, yet no data is available on its prevalence in tumours diagnosed during pregnancy. Methods: We evaluated the prevalence of TILs (stromal and intratumoural) in pregnant and non-pregnant young breast cancer patients. Results: 11/116 (9.6%) of the non-pregnant and 2/86 (2.3%) pregnant patients had TILs≥50% (p

AB - Background: Tumour infiltrating lymphocytes (TILs) is one of the most exciting breast cancer biomarkers, yet no data is available on its prevalence in tumours diagnosed during pregnancy. Methods: We evaluated the prevalence of TILs (stromal and intratumoural) in pregnant and non-pregnant young breast cancer patients. Results: 11/116 (9.6%) of the non-pregnant and 2/86 (2.3%) pregnant patients had TILs≥50% (p

KW - Biology

KW - Breast cancer during pregnancy

KW - Tumour infiltrating lymphocytes

KW - Young

UR - http://www.scopus.com/inward/record.url?scp=84931372511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931372511&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2015.01.009

DO - 10.1016/j.breast.2015.01.009

M3 - Article

VL - 24

SP - 290

EP - 293

JO - Breast

JF - Breast

SN - 0960-9776

IS - 3

ER -